Explicit Ligand Hydration Shells Improve the Correlation between MM-PB/GBSA Binding Energies and Experimental Activities.

Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) and Molecular Mechanics Generalized Born Surface Area (MM-GBSA) methods are widely used for drug design/discovery purposes. However, it is not clear if the correlation between predicted and experimental binding affinities can be improved by explicitly considering selected water molecules in the calculation of binding energies, since different and sometimes diverging opinions are found in the literature. In this work, we evaluated how variably populated hydration shells explicitly considered around the ligands may affect the correlation between MM-PB/GBSA computed binding energy and biological activities (IC50 and ΔGbind, depending on the available experimental data). Four different systems-namely, the DNA-topoisomerase complex, α-thrombin, penicillopepsin, and avidin-were considered and ligand hydration shells populated by 10-70 water molecules were systematically evaluated. We found that the consideration of a hydration shell populated by a number of water residues (Nwat) between 30 and 70 provided, in all of the considered examples, a positive effect on correlation between MM-PB/GBSA calculated binding affinities and experimental activities, with a negligible increment of computational cost.

[1]  D. Case,et al.  Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.

[2]  John Moult,et al.  Crystallographic Analysis of a Pepstatin Analogue Binding to the Aspartyl Proteinase Penicillopepsin at 1.8 Angstroms Resolution , 1994 .

[3]  R. Salgia,et al.  A review of topoisomerase inhibition in lung cancer , 2006, Cancer biology & therapy.

[4]  P. Charifson,et al.  Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system. , 2001, Journal of medicinal chemistry.

[5]  P. Kollman,et al.  Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models. , 2000, Journal of medicinal chemistry.

[6]  Samuel Genheden,et al.  Comparison of end‐point continuum‐solvation methods for the calculation of protein–ligand binding free energies , 2012, Proteins.

[7]  J. Andrew McCammon,et al.  MM-PBSA Captures Key Role of Intercalating Water Molecules at a Protein−Protein Interface , 2009, Journal of chemical theory and computation.

[8]  R. Constanciel,et al.  Self consistent field theory of solvent effects representation by continuum models: Introduction of desolvation contribution , 1984, Theoretica chimica acta.

[9]  Jacob Kongsted,et al.  An improved method to predict the entropy term with the MM/PBSA approach , 2009, J. Comput. Aided Mol. Des..

[10]  Ray Luo,et al.  Virtual screening using molecular simulations , 2011, Proteins.

[11]  N M Green,et al.  Thermodynamics of the binding of biotin and some analogues by avidin. , 1966, The Biochemical journal.

[12]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[13]  Eamonn F. Healy,et al.  Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model , 1985 .

[14]  Georgios Archontis,et al.  Kinetics, in silico docking, molecular dynamics, and MM‐GBSA binding studies on prototype indirubins, KT5720, and staurosporine as phosphorylase kinase ATP‐binding site inhibitors: The role of water molecules examined , 2011, Proteins.

[15]  G. Fontana,et al.  Molecular dynamics and tubulin polymerization kinetics study on 1,14-heterofused taxanes: evidence of stabilization of the tubulin head-to-tail dimer-dimer interaction. , 2012, Molecular bioSystems.

[16]  Ly Le,et al.  Explicitly solvated ligand contribution to continuum solvation models for binding free energies: selectivity of theophylline binding to an RNA aptamer. , 2010, The journal of physical chemistry. B.

[17]  P. Kollman,et al.  Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding , 2000 .

[18]  Jan Hermans,et al.  Promise of advances in simulation methods for protein crystallography: implicit solvent models, time-averaging refinement, and quantum mechanical modeling. , 2003, Methods in enzymology.

[19]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[20]  Lance Stewart,et al.  The mechanism of topoisomerase I poisoning by a camptothecin analog , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[22]  D. Banner,et al.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.

[23]  F. Zunino,et al.  Synthesis, structural, and biological evaluation of bis-heteroarylmaleimides and bis-heterofused imides. , 2011, Bioorganic & medicinal chemistry.

[24]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[25]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[26]  Piotr Cieplak,et al.  The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. , 2010, Physical chemistry chemical physics : PCCP.

[27]  Samuel Genheden,et al.  How to obtain statistically converged MM/GBSA results , 2009, J. Comput. Chem..

[28]  William L. Jorgensen,et al.  Improved convergence of binding affinities with free energy perturbation: Application to nonpeptide ligands with pp60src SH2 domain , 2001, J. Comput. Aided Mol. Des..

[29]  D. Case Normal mode analysis of protein dynamics , 1994 .

[30]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[31]  P. Kollman,et al.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. , 2000, Accounts of chemical research.

[32]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[33]  G. Narahari Sastry,et al.  Molecular Dynamics Investigation on a Series of HIV Protease Inhibitors: Assessing the Performance of MM-PBSA and MM-GBSA Approaches , 2012, J. Chem. Inf. Model..

[34]  Klaus R. Liedl,et al.  A challenging system: Free energy prediction for factor Xa , 2011, J. Comput. Chem..

[35]  Michael H. Gelb,et al.  Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. , 1994 .

[36]  A Coda,et al.  Three-dimensional structure of the tetragonal crystal form of egg-white avidin in its functional complex with biotin at 2.7 A resolution. , 1993, Journal of molecular biology.

[37]  F. Clerici,et al.  1H-Azepine-4-amino-4-carboxylic acid: a new α,α-disubstituted ornithine analogue capable of inducing helix conformations in short Ala-Aib pentapeptides. , 2012, Chemistry.

[38]  Lenwood S. Heath,et al.  H++: a server for estimating pKas and adding missing hydrogens to macromolecules , 2005, Nucleic Acids Res..

[39]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[40]  Yves Pommier,et al.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. , 2010, Chemistry & biology.

[41]  M. James,et al.  Macrocyclic Inhibitors of Penicillopepsin. 2. X-ray Crystallographic Analyses of Penicillopepsin Complexed with a P3−P1 Macrocyclic Peptidyl Inhibitor and with Its Two Acyclic Analogues , 1998 .

[42]  Andriy Kovalenko,et al.  An MM/3D-RISM approach for ligand binding affinities. , 2010, The journal of physical chemistry. B.

[43]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[44]  F. Clerici,et al.  Molecular dynamic simulation of mGluR5 amino terminal domain: essential dynamics analysis captures the agonist or antagonist behaviour of ligands. , 2013, Journal of molecular graphics & modelling.

[45]  M. Zhang,et al.  The crystal structures of human α‐thrombin complexed with active site‐directed diamino benzo[b] thiophene derivatives: A binding mode for a structurally novel class of inhibitors , 2008, Protein science : a publication of the Protein Society.

[46]  U. Ryde,et al.  Ligand affinities predicted with the MM/PBSA method: dependence on the simulation method and the force field. , 2006, Journal of medicinal chemistry.

[47]  Christian Kramer,et al.  MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement , 2013, J. Chem. Inf. Model..

[48]  A. Ortiz,et al.  Assessment of solvation effects on calculated binding affinity differences: trypsin inhibition by flavonoids as a model system for congeneric series. , 1997, Journal of medicinal chemistry.

[49]  F. Clerici,et al.  3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides: a new class of selective Rac inhibitors , 2013 .

[50]  J. Åqvist,et al.  Ligand binding affinities from MD simulations. , 2002, Accounts of chemical research.

[51]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[52]  F. Zunino,et al.  Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides. , 2008, Bioorganic & medicinal chemistry.

[53]  S. Moro,et al.  Semisynthesis, biological activity, and molecular modeling studies of C-ring-modified camptothecins. , 2009, Journal of medicinal chemistry.

[54]  F. Clerici,et al.  Virtual screening approach for the identification of new Rac1 inhibitors. , 2009, Journal of medicinal chemistry.